MIF and COVID-19: With accumulating evidence pointing towards a critical role of MIF as a prognostic marker to predict disease severity and patient outcome in COVID-19 and observations of an impaired T cell response during Sars-CoV-2 infections often displayed by sustained T-cell activation, we aimed to confirm the translational relevance of our findings in the context of COVID-19 [30–32].